Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Cancer Immunotherapy Global Market, By Product & Data Validation, 2016 Analysis and Forecast 2022

(, November 14, 2017 ) According to Publisher, the Global Cancer Immunotherapy market is estimated at $54.35 billion in 2015 and is expected to reach $147.25 billion by 2022 growing at a CAGR of 15.3% from 2015 to 2022. Rapid increase in cases of cancer across the globe, smoking and excessive consumption of alcohol which causes cancer are some of the factors fueling the market growth. High cost for the treatment is hampering the market growth. On the other hand rise in clinical trials against different cancers in immunotherapy is the opportunity for the market growth.

For more information about this report:

Monoclonal Antibodies accounted for the largest share in product type segment and expected to be fastest growing during forecast period. North America captured largest share owing to high mortality rate among cancer patients and government initiative programs to create awareness among the people. Asia Pacific region is expected to be fastest growing during forecast period.

Some of the key players in the market include GlaxoSmithKline, Eli Lilly and Company, F. Hoffmann-LA Roche Ltd, Amgen Inc., Ablynx NV, Bristol-Myers Squibb, Janssen Global Services, LLC (Johnson and Johnson), Astrazeneca, Biovest International Inc, Bayer AG, Oxford BioTherapeutics Ltd., Pfizer, Genentech Inc, Merck, Bellicum Pharmaceuticals Inc and Novartis

Applications Covered:
- Multiple Myeloma
- Prostate Cancer
- Head & Neck Cancer
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Breast Cancer
- Other Cancer Types

Product Types Covered:
- Vaccines
o Therapeutic Vaccines
o Prophylactic Vaccines
- Immunomodulators
o Granulocyte/Macrophage Colony-Stimulating Factor (GM-CSF & G-CSF)
o Oncolytic Virus
 Immunity as an Ally
 Immunotherapy
 Approved Products & Clinical Trails
 Immunity as an Obstacle
o Interferons (IFN)
o Interleukins (IL)
- Monoclonal Antibodies
o Bispecific Monoclonal Antibodies
o Naked Monoclonal Antibodies
o Conjugated Monoclonal Antibodies
- Cell Therapies
o Dendritic Cells
o Chimeric Antigen Receptor (CAR) T Cell Therapy
- Check Point Inhibitors
o Programmed Death 1 (PD-1) and Programmed Death Ligand 1 (PD-L1)
o Cytotoxic T-Lymphocyte-Associated Protein-4 (CTLA-4)

Request Sample Copy at

End Users Covered:
- Clinics
- Hospital
- Other End Users

Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Company Profiling
10.1 GlaxoSmithKline
10.2 Eli Lilly and Company
10.3 F. Hoffmann-LA Roche Ltd
10.4 Amgen Inc.
10.5 Ablynx NV
10.6 Bristol-Myers Squibb
10.7 Janssen Global Services, LLC (Johnson and Johnson)
10.8 Astrazeneca
10.9 Biovest International Inc
10.10 Bayer AG
10.11 Oxford BioTherapeutics Ltd.
10.12 Pfizer
10.13 Genentech Inc
10.14 Merck
10.15 Bellicum Pharmaceuticals Inc
10.16 Novartis

Inquire before Buying at

Rajat Sahni


Source: EmailWire.Com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.

GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | | i-Canada-News.Com | | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | | | | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | - Medicl Newswire and Press Release service of GroupWeb Media LLC